Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.

[1]  Hee-Yong Kim.  Novel Metabolism of Docosahexaenoic Acid in Neural Cells* , 2007, Journal of Biological Chemistry.

[2]  C. Chen,et al.  The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. , 2006, Life sciences.

[3]  F. Guengerich,et al.  A malleable catalyst dominates the metabolism of drugs , 2006, Proceedings of the National Academy of Sciences.

[4]  T. Sjögren,et al.  Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.

[5]  J. Falck,et al.  Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  L. Corcos,et al.  Determination of polyunsatured fatty acid monoepoxides by high performance liquid chromatography–mass spectrometry , 2006 .

[7]  Julian P T Higgins,et al.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review , 2006, BMJ : British Medical Journal.

[8]  F. Guengerich,et al.  In Vitro techniques for studying drug metabolism , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  Eduardo Barbosa-Sicard,et al.  Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. , 2005, Biochemical and biophysical research communications.

[10]  E. Oliw,et al.  Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes. , 2005, Biochemical and biophysical research communications.

[11]  S. Imaoka,et al.  Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. , 2005, Drug metabolism and pharmacokinetics.

[12]  Eric F. Johnson,et al.  The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.

[13]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[14]  J. Schenkman,et al.  Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[15]  P. Potin,et al.  Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxidess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional four tables and six figures. Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300463-JLR200 , 2004, Journal of Lipid Research.

[16]  Magnus Ingelman-Sundberg,et al.  Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. , 2004, The American journal of clinical nutrition.

[17]  Spencer S. Ericksen,et al.  Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. , 2004, Biochemical pharmacology.

[18]  C David Stout,et al.  Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.

[19]  Xiang Fang,et al.  Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. , 2004, Progress in lipid research.

[20]  James R. Halpert,et al.  An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[22]  Hon-chi Lee,et al.  Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.

[23]  Eric F. Johnson,et al.  The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands* , 2002, The Journal of Biological Chemistry.

[24]  J. Falck,et al.  Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. , 2002, Prostaglandins & other lipid mediators.

[25]  D. Kroetz,et al.  Cytochrome P450 pathways of arachidonic acid metabolism , 2002, Current opinion in lipidology.

[26]  J. Falck,et al.  Microsomal cytochrome P450 and eicosanoid metabolism , 2002, Cellular and Molecular Life Sciences CMLS.

[27]  J. Goldstein,et al.  Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. , 2002, Pharmacogenetics.

[28]  H. Mohrenweiser,et al.  Cloning of CYP2J2 gene and identification of functional polymorphisms. , 2002, Molecular pharmacology.

[29]  D. Jump.  The Biochemistry of n-3 Polyunsaturated Fatty Acids* 210 , 2002, The Journal of Biological Chemistry.

[30]  M. Gollasch,et al.  Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators , 2002, Hypertension.

[31]  R. Roman,et al.  P-450 metabolites of arachidonic acid in the control of cardiovascular function. , 2002, Physiological reviews.

[32]  A. Brash.  Arachidonic acid as a bioactive molecule. , 2001, The Journal of clinical investigation.

[33]  J. Pascussi,et al.  Induction of CYP2C genes in human hepatocytes in primary culture. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[34]  P. Ortiz de Montellano,et al.  Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. , 2000, Archives of biochemistry and biophysics.

[35]  E. Oliw,et al.  Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS. , 1998, Analytical biochemistry.

[36]  D. Fulton,et al.  A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. , 1998, Journal of lipid research.

[37]  K Chiba,et al.  Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes. , 1998, Biochemical pharmacology.

[38]  J. Lasker,et al.  Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. , 1998, The Journal of pharmacology and experimental therapeutics.

[39]  E. Oliw,et al.  Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. , 1998, The Journal of pharmacology and experimental therapeutics.

[40]  R. Murphy,et al.  Analysis of epoxyeicosatrienoic and monohydroxyeicosatetraenoic acids esterified to phospholipids in human red blood cells by electrospray tandem mass spectrometry. , 1997, Journal of mass spectrometry : JMS.

[41]  K. Tomer,et al.  Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. , 1996, Archives of biochemistry and biophysics.

[42]  K. Tomer,et al.  Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart (*) , 1996, The Journal of Biological Chemistry.

[43]  R. DuBois,et al.  Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. , 1995, Archives of biochemistry and biophysics.

[44]  D. Waxman,et al.  Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. , 1995, Archives of biochemistry and biophysics.

[45]  D. Koop,et al.  Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. , 1994, The Journal of pharmacology and experimental therapeutics.

[46]  R. Murphy,et al.  Collisionally induced dissociation of epoxyeicosatrienoic acids and epoxyeicosatrienoic acid-phospholipid molecular species. , 1991, Analytical biochemistry.

[47]  O. Carretero,et al.  Oxidation of 5,8,11,14,17-eicosapentaenoic acid by hepatic and renal microsomes. , 1988, Biochimica et biophysica acta.

[48]  R. Murphy,et al.  Oxidation of docosahexaenoic acid by rat liver microsomes. , 1984, The Journal of biological chemistry.

[49]  J. Oates,et al.  Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. , 1982, The Journal of biological chemistry.

[50]  L. Marnett,et al.  Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.